Skip to main content

Remote Job Finders (RJF)

July Layoffs Skyrocket 487% YOY With Merck Cuts

The number of biopharma professionals let go has increased year over year for three straight months. In July, nearly 8,000 people lost their jobs, due largely to Merck cutting roughly 6,000 employees. Sarepta Therapeutics and Moderna also announced significant workforce reductions.

Trial Failure of Vertex’s Next-Gen Pain Drug Mars Strong Q2 Earnings

Vertex reported healthy revenue in its second quarter earnings report, though news of VX-993’s mid-stage trial results and lack of alignment with the FDA regarding an expanded label for Journavx tempered analyst reactions, sending the stock down 13%.
Scroll to top